Witness Testimony

Dr. Jessica Rose testified that the COVID-19 mRNA products were rushed through truncated clinical trials in which placebo groups were unblinded and long-term safety data were lost. She stated that genuine long-term safety testing was impossible within the compressed timeline and argued that the “safe and effective” claims were not supported by adequate follow-up. She further testified that early VAERS data in January 2021 already demonstrated a strong safety signal, including hundreds of reported deaths, and that the scale of reported adverse events was historically unprecedented compared to prior vaccines. She calculated a 1,300–1,400% increase in VAERS reporting metrics in 2021 and argued that underreporting likely means actual injury counts are significantly higher.
Rose testified that the lipid nanoparticle delivery system distributes beyond the injection site, including to the liver and ovaries, and that spike protein production may persist in multiple tissues. She described potential mechanisms for harm involving ACE2 binding, renin–angiotensin system dysregulation, clotting cascade disruption, and persistent spike-mediated inflammation. She further discussed the possibility that amyloidogenic spike fragments could contribute to unusual fibrous clots described by embalmers, and she questioned whether some myocarditis diagnoses in youth may instead represent cardiac amyloidosis. She also raised concerns about reported double-stranded DNA contamination from plasmid templates used in manufacturing.
She testified that pharmacovigilance systems such as VAERS are not being properly utilized, alleging that proportional reporting ratio analyses, Bayesian assessments, and causality investigations have not been conducted as historically done. She criticized suppression of adverse event reporting, discouragement within clinical settings, and professional consequences for researchers raising safety concerns. Rose concluded that while definitive genomic integration evidence is not yet established, the theoretical potential exists, and she called for greater transparency, independent oversight, autopsy investigation, and immediate reassessment of ongoing vaccine administration.